These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1286995)

  • 1. Plasmapheresis therapy is ineffective in SLE. Lupus Nephritis Collaborative Study Group.
    Lewis EJ
    J Clin Apher; 1992; 7(3):153. PubMed ID: 1286995
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment protocols of the lupus nephritis collaborative study of plasmapheresis in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.
    Clough JD; Lewis EJ; Lachin JM
    Prog Clin Biol Res; 1990; 337():301-7. PubMed ID: 2352989
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasmapheresis for lupus nephritis.
    Robinson JA
    N Engl J Med; 1992 Oct; 327(14):1028-9; author reply 1029-30. PubMed ID: 1472252
    [No Abstract]   [Full Text] [Related]  

  • 4. The therapeutic potential of plasmapheresis in systemic lupus erythematosus (SLE).
    Swaak AJ
    Neth J Med; 1988 Oct; 33(3-4):155-9. PubMed ID: 3226448
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasmapheresis combined with corticosteroids and cyclophosphamide in uncontrolled active systemic lupus erythematosus.
    Schildermans F; Dequeker J; Van de Putte I
    J Rheumatol; 1979; 6(6):687-90. PubMed ID: 529252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil].
    Sixdorf U; Bauer H; Märker-Hermann E
    Dtsch Med Wochenschr; 2006 Oct; 131(41):2266-9. PubMed ID: 17036267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of systemic lupus erythematosus in adults and children.
    Miller ML
    Curr Opin Rheumatol; 1990 Oct; 2(5):712-6. PubMed ID: 2265068
    [No Abstract]   [Full Text] [Related]  

  • 8. A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.
    Lewis EJ; Hunsicker LG; Lan SP; Rohde RD; Lachin JM
    N Engl J Med; 1992 May; 326(21):1373-9. PubMed ID: 1569973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systemic lupus erythematosus].
    Schröder JO; Euler HH
    Internist (Berl); 1993 Apr; 34(4):351-61. PubMed ID: 8486478
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of systemic lupus erythematosus in two patients with extreme B-cell lymphopenia: importance of immunomonitoring and avoidance of B-cell targeted therapy.
    Gluhovschi C; Gluhovschi G; Herman D; Trandafirescu V; Petrica L; Velciov S; Bozdog G; Bob F; Cioca D
    Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):562-8. PubMed ID: 20128658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lupus erythematosus; current treatment methods].
    Nossent JC
    Ned Tijdschr Geneeskd; 1993 Mar; 137(11):558. PubMed ID: 8464532
    [No Abstract]   [Full Text] [Related]  

  • 12. [Synchronizing therapy with plasmapheresis and cyclophosphamide in rapidly progressing systemic lupus erythematosis with kidney involvement].
    Demin AA; Sentiakova TN; Smirnov VV; Demina LM; Mamin IV
    Ter Arkh; 1996; 68(5):27-30. PubMed ID: 9082593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasmapheresis combined with pharmacology in the treatment of lupus nephritis: a new therapeutic protocol].
    Russo GE; Bonello M; Vitaliano E; Bosco M; Maresca L; De Paola A; Tedaldi M; Bisciglia MF; Bauco B
    Clin Ter; 2000; 151(1):9-13. PubMed ID: 10822875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic plasmapheresis in systemic lupus erythematosus. Effect on immune complexes and antibodies to DNA.
    Jones JV; Robinson MF; Parciany RK; Layfer LF; McLeod B
    Arthritis Rheum; 1981 Sep; 24(9):1113-20. PubMed ID: 6975635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lupus nephritis with nephrotic syndrome successfully treated with plasmapheresis and cyclophosphamide].
    Obroniecka I; Korsak J; Wańkowicz Z
    Pol Arch Med Wewn; 1994 Mar; 91(3):227-31. PubMed ID: 8029131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis.
    Danieli MG; Palmieri C; Salvi A; Refe MC; Strusi AS; Danieli G
    J Clin Apher; 2002; 17(2):72-7. PubMed ID: 12210709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lupus nephritis. 3: Therapeutic approach].
    Guérin S; Léveillé M
    Union Med Can; 1982 Feb; 111(2):91-5, 133. PubMed ID: 7080269
    [No Abstract]   [Full Text] [Related]  

  • 18. The application of plasmapheresis in systemic lupus erythematosus.
    Jones JV
    Prog Clin Biol Res; 1982; 106():81-9. PubMed ID: 6817336
    [No Abstract]   [Full Text] [Related]  

  • 19. Termination of a clinical trial with no treatment group difference: the Lupus Nephritis Collaborative Study.
    Lachin JM; Lan SP
    Control Clin Trials; 1992 Feb; 13(1):62-79. PubMed ID: 1315665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide.
    Levey AS; Lan SP; Corwin HL; Kasinath BS; Lachin J; Neilson EG; Hunsicker LG; Lewis EJ
    Ann Intern Med; 1992 Jan; 116(2):114-23. PubMed ID: 1727614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.